Viking Therapeutics, Inc. (VKTX)
33.23
-0.66
(-1.95%)
USD |
NASDAQ |
Aug 24, 16:00
33.60
+0.37
(+1.11%)
After-Hours: 06:22
Viking Therapeutics Max Drawdown (5Y) : 89.26% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 89.26% |
| June 30, 2026 | 89.26% |
| May 31, 2026 | 89.26% |
| April 30, 2026 | 89.26% |
| March 31, 2026 | 89.26% |
| February 28, 2026 | 89.26% |
| January 31, 2026 | 89.26% |
| December 31, 2025 | 89.26% |
| November 30, 2025 | 89.26% |
| October 31, 2025 | 89.26% |
| September 30, 2025 | 89.26% |
| August 31, 2025 | 89.26% |
| July 31, 2025 | 89.26% |
| June 30, 2025 | 89.26% |
| May 31, 2025 | 89.26% |
| April 30, 2025 | 89.26% |
| March 31, 2025 | 89.26% |
| February 28, 2025 | 89.26% |
| January 31, 2025 | 89.26% |
| December 31, 2024 | 89.26% |
| November 30, 2024 | 89.26% |
| October 31, 2024 | 89.26% |
| September 30, 2024 | 89.26% |
| August 31, 2024 | 89.26% |
| July 31, 2024 | 89.26% |
| Date | Value |
|---|---|
| June 30, 2024 | 89.26% |
| May 31, 2024 | 89.26% |
| April 30, 2024 | 89.26% |
| March 31, 2024 | 89.26% |
| February 29, 2024 | 89.26% |
| January 31, 2024 | 89.26% |
| December 31, 2023 | 89.26% |
| November 30, 2023 | 89.26% |
| October 31, 2023 | 89.26% |
| September 30, 2023 | 89.26% |
| August 31, 2023 | 89.26% |
| July 31, 2023 | 89.26% |
| June 30, 2023 | 89.26% |
| May 31, 2023 | 89.26% |
| April 30, 2023 | 89.26% |
| March 31, 2023 | 89.26% |
| February 28, 2023 | 89.26% |
| January 31, 2023 | 89.26% |
| December 31, 2022 | 89.26% |
| November 30, 2022 | 89.26% |
| October 31, 2022 | 89.26% |
| September 30, 2022 | 89.26% |
| August 31, 2022 | 89.26% |
| July 31, 2022 | 90.41% |
| June 30, 2022 | 90.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Vertex Pharmaceuticals, Inc. | 41.60% |
| Eli Lilly & Co. | 34.47% |
| Regeneron Pharmaceuticals, Inc. | 59.69% |
| Skye Bioscience, Inc. | 99.47% |
| Eledon Pharmaceuticals, Inc. | 99.05% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 28.80 |
| Beta (5Y) | 0.6943 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 124.8% |
| Historical Sharpe Ratio (5Y) | 0.282 |
| Historical Sortino (5Y) | 1.134 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.71% |